Diagnostic test developers, including clinical laboratories, responded to the COVID-19 pandemic with inspiring creativity to meet patient testing needs. These developers found unique ways to enable ...
“We are thrilled to begin testing anywhere in the United States and worldwide with our first-of-their-kind mobile labs,” said Eric Canonico, CEO of MOTOPARA Foundation. “With the recent surge of COVID ...
CE-marked under the EU IVDR regulation, Diagnostics.AI's platform is the first to deliver AI algorithmic transparency and per-test auditability for clinical PCR diagnostics As the May 26th CE-IVDR ...
Modifications and adaptations continue to improve how we use PCR, spurring a new level of creativity in genomics hypotheses and enabling a broad versatility in applications. PCR has the speed, ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical ...
Labroots is excited to host the 16th Annual Clinical Diagnostics & Research Virtual Event Series on November 12, 2025. This premier online event unites clinicians, lab professionals, and researchers ...
Dublin, Sept. 05, 2017 (GLOBE NEWSWIRE) -- The "PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)" report has been added to Research and Markets' offering. The report ...
Hospitals and health systems face growing pressure to outsource their clinical laboratories amid an increasing number of healthcare mergers and acquisitions. As healthcare leaders weigh the perceived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback